Peter E. Weeke
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial.
Journal: JAMA cardiology
Published: December 23, 2025
External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.
Journal: PharmacoEconomics
Published: December 12, 2025
Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT Trial.
Journal: PharmacoEconomics
Published: June 06, 2025
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.
Journal: Lancet (London, England)
Published: May 13, 2025
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity.
Journal: Journal of the American College of Cardiology
Published: October 18, 2024
Family history of cardiovascular disease and death in patients with out-of-hospital cardiac arrest.
Journal: Resuscitation plus
Published: October 15, 2024
Subgrouping patients with ischemic heart disease by means of the Markov cluster algorithm.
Journal: Communications medicine
Published: August 22, 2024
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT Trial.
Journal: Journal of the American College of Cardiology
Published: July 25, 2024
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
Journal: Lancet (London, England)
Published: July 18, 2024
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Journal: Lancet (London, England)
Published: June 03, 2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.
Journal: Diabetes care
Published: April 12, 2024
Correction: Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiography.
Journal: PloS one
Published: October 26, 2023
Last Updated: 09/26/2026